Rosana Steavenson, PharmD, BCPS, BCPP Program Manager, Mental Health and Pain Clinical Pharmacy Programs Mental Health Clinical Pharmacist Practitioner South Texas Veterans Health Care System, San Antonio, TX
Searching for Solutions
The “What I Wish I Knew” series of articles is a service of CPNP’s Resident and New Practitioner Committee. Articles are intended to provide advice from experts for students, residents, and new practitioners. Articles are not intended to provide in-depth disease state or pharmacotherapy information nor replace any peer-reviewed educational materials.
No summary available
0.75
hours
hours
Expires:
06/01/2029
No summary available
0.75
hours
hours
Expires:
06/01/2029
No summary available
1
hour
hour
Expires:
06/01/2029
No summary available
0.5
hours
hours
Expires:
06/01/2029
"While working with the inpatient unit, I learned more about the transition of care to our outpatient Women's Mood Disorder clinic, the site for my ambulatory rotation during residency. My residency program director coordinated with the attending physician who oversaw the clinic, and I was immediately acknowledged as a member of the team. I was the first pharmacist to practice in this setting, which was a valuable experience in and of itself.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients, improving outcomes and saving lives.
Suzanne C. Harris, PharmD, BCPP, CPP Director of Well-being and Resilience Associate Professor Clinical Pharmacist Practitioner- Psychiatry
Chris Paxos, PharmD, BCPP, BCPS, BCGP Director, Pharmacotherapy Professor, Pharmacy Practice Northeast Ohio Medical University Rootstown, OH Dr. Paxos received his Doctor of Pharmacy from Ohio Northern University in Ada, OH.
No summary available
No summary available
No summary available
Congratulations to AAPP member and Past-President Dr. Deanna Kelly, PharmD, BCPP, named by the National Alliance on Mental Illness (NAMI) as the 2026 recipient of its prestigious Scientific Research Award! The honor, which recognizes groundbreaking contributions to the understanding and treatment of mental illness, was presented at the organization’s national convention, NAMICon, May 27–30, 2026 in Atlanta, Georgia. Dr.
These findings suggest that glucagon-like peptide-1 receptor agonist monotherapy may alter some nicotine outcomes in people who smoke, irrespective of cessation treatment.
GLP-1 RA use in adults on methadone with both OUD and T2D was associated with lower rates of cardiometabolic and mental health complications.
Findings suggest brief educational interventions can help primary care providers recognize misinformation that may otherwise undermine implementation efforts.
This study conducted a systematic review following PRISMA 2020 guidelines.
Authored by AAPP members Zoe Karavolis, Emily Leppien and Annette Percy, AAPP has released an FAQ to help clinicians address frequently asked questions regarding the use of buprenorphine and methadone in acute care settings.
AAPP's Psychotropic LAI Training Program is back and full of updates! This grant-funded educational activity is offered complimentary and includes access to 6 webinars and LAI resources like a pocket-guide, administration videos, and more. Register today and help us share this program with others that would find it valuable.
No summary available
SAMHSA Resource - Healthy Starts: Postpartum OUD Care Transitions for Mother and Infant (Case Study)
This publication highlights best practices for managing OUD during and after pregnancy and summarizes current evidence on treating perinatal substance use disorder.
Get certified in Mental Health First Aid! The next course is on July 16 and is completely free to attend, courtesy of the AAPP Foundation. Seats are filling up! Save your spot today.
Nearly 1 in 5 adolescents and young adults are turning to AI chatbots for advice when they’re sad, angry, nervous or stressed, according to a new study. The findings, from the research institute RAND, represent an increase from early 2025, when the nonprofit conducted a similar survey. At the time, around 13% of respondents said they used chatbots for such advice, but the share rose to 19% in the group’s latest survey in November.
This report used literature review and data analysis to gain insight into existing research and the real-world impact by examining Medicare fee-for-service and Part D data from 2021 to 2023.